Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C

Kose Ş., Senger S. S., Ersan G., Cavdar G.

CLINICAL AND EXPERIMENTAL NEPHROLOGY, cilt.17, sa.1, ss.115-119, 2013 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s10157-012-0663-x
  • Dergi Adı: CLINICAL AND EXPERIMENTAL NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.115-119
  • Anahtar Kelimeler: Hepatitis C, Interferon, Hemodialysis patients, STAGE RENAL-DISEASE, VIRUS-INFECTION, DIALYSIS PATIENTS, VIRAL-HEPATITIS, EFFICACY, RIBAVIRIN, MANAGEMENT, PEGYLATED-INTERFERON-ALPHA-2A, TRANSPLANTATION, METAANALYSIS
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Hepatitis C is the most frequently encountered hepatic disease in dialysis patients. Data related to pegylated interferon alfa-2a (Peg-IFN-alpha-2a) use in hemodialysis patients with hepatitis C virus (HCV) are limited. The aim of this study was to evaluate the efficacy of Peg-IFN-alpha-2a among these patients.